Dosage form comprising oxybutynin

  • US 5,674,895 A
  • Filed: 05/22/1995
  • Issued: 10/07/1997
  • Est. Priority Date: 05/22/1995
  • Status: Expired due to Term
First Claim
Patent Images

1. A therapeutic composition comprising:

  • 1 ng to 450 mg of oxybutynin, 40 mg to 250 mg of polyalkylene oxide, 1 mg to 25 mg of hydroxypropylalkylcellulose, and 0.01 mg to 5 mg of a lubricant.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×